Arbuthnot et al., “In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector” Human Gene Ther. 7:1503-1514 (1996). |
Arnberg et al., “Fiber genes of adenoviruses with tropism for the eye and the genital tract” Virol. 227:239-244 (1997). |
Bailey et al., “Cell type specific regulation of expression from the Ad40 E1B promoter in recombinant Ad5/Ad40 viruses” Virology 202:695-706 (1994). |
Bailey et al., “Enteric adenovirus type 40: Expression of E1B proteins in vitro and in vivo” Virology 193:631-641 (1993). |
Behringer et al., “Dwarf mice produced by genetic ablation of growth hormone-expressing cells” Genes Dev. 2:453-461 (1988). |
Berkner and Sharp, “Generation of adenovirus by transfection of plasmids” Nucl. Acids Res. 11(17):6003-6020 (1983). |
Bett et al., “An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3” Proc. Natl. Acad. Sci USA 91:8802-8806 (1994). |
Bett et al., “Packaging capacity and stability of human adenovirus type 5 vectors” J. Virology 67(10):5911-5921 (1993). |
Bischoff et al., “An adenovirus mutant that replicates selectively in p53-deficient human tumor cells,” Science 274(5286):373-376 (1996). |
Braun et al. “Immunogenic duplex nucleic acids are nuclease resistant” J. Immunol. 141(6):2084-1089 (1988). |
Bridge et al., “Redundant control of adenovirus late gene expression by early region 4” J. Virol. 63(2):631-638 (1989). |
Chang et al., “Cancer Gene Therapy Using novel tumor specific replication competent adenoviral vectors” Cold Spring Harbor Gene Therapy Meeting, p. 53 (1996). |
Chaturvedi et al., “Stabilization of triple-stranded oligonucleotide complexes: use of probes containing alternating phosphodiester and stereo-uniform cationic phosphoramidate linkages” Nucleic Acids Res. 24(12):2318-2323 (1996). |
Current Protocols in Molecular Biology (Ausubel et al., eds., 1987) Supp. 30, Section 7.7.18-19, Table 7.7.1. |
Emerson et al., “The zonal expression of alpha-fetoprotein transgenes in the livers of adult mice” Devel. Dynamics 195:55-65 (1992). |
Felgner and Ringold, “Cationic liposome-mediated tranfection” Nature 337:387-388 (1989). |
Flint “Expression of adenoviral genetic information in productively infected cells” Biochem. Biophys. Acta 651:175-208 (1982). |
Flint “Regulation of adenovirus mRNA formation” Advances Virus Research 31:169-228 (1986). |
Frankel et al., “Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae” Mol. Cell. Biol. 9(2):415-420 (1989). |
Ghebranious et al., “Developmental control of transcription of the cat reporter gene by a truncated mouse alphafetoprotein gene regulatory region in transgenic mice” Mo. Reprod. Devel. 42:1-6 (1995). |
Graham et al., “A new technique for the assay of infectivity of human adenovirus 5 DNA” Virology 52:456-467 (1973). |
Graham et al. “Characteristics of a human cell line transformed by DNA from human adenovirus type 5” J. Gen. Virol. 36:59-72 (1977). |
Graham, “Covalently closed circles of human adenovirus DNA are infectious” EMBO Journal 3(12):2917-2922 (1984). |
Graham, “Growth of 293 cells in suspension culture” J. Genetic Virology 68:937-940 (1987). |
Grand, “The structure and functions of the adenovirus early region 1 proteins” Biochem. J. 241:25-38 (1987). |
Groupp et al. “Characterization of the distal alpha-fetoprotein enhancer, a strong, long distance, liver specific activator” J. Biol. Chem. 269(35):22178-22187 (1994). |
Hallenbeck, O. et al., “Novel Tumor Specific Replication Competent Adenoviral Vectors for Gene Therapy of Cancer” Cancer Gene Therapy, 3(6):S19-S20 (1996). |
Hayashi et al., “Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor” J. Biol. Chem. 269(39):23872-23875 (1994). |
Huber et al., “VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastic colorectal cancer” Adv. Drug Delivery Rev. 17:279-292 (1995). |
Ido et al., “Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter” Cancer Res. 55(14):3105-1309 (1995). |
Jaffe et al., “Adenovirus-mediated in vivo gene transfer and expression in normal rat liver” Nat. Genet. 1:372-378 (1992). |
Kanai et al., “Adenovirally directed enzyme prodrug therapy again hepatocellular carcinoma” Hepatology 22(4 Part 2):188A Abstract No. 328 (1995). |
Kanai et al., “Gene therapy for hepatocellular carcinom: Chemosensitivity conferred by adenovirus-mediated transfer of the suicide gene” Gastroenterol. 110(4):A1227 Suppl. (1996). |
Kanai et al., “Gene Therapy for an alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene” Hepatology 23(6):1359-1368 (1996). |
Kanai et al., “Prolonged survival of mice bearing disseminated gastric cancer by adenovirus-mediated gene therapy” Cancer Gene Ther. 3(6):S32 Abstract No. P-82 (1996). |
Kaneko et al., “Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression” Cancer Res. 5:5283-5287 (1995). |
Kaneko et al., “Gene therapy of hepatocellular carcinoma using the alpha-fetoprotein in an adenoviral vector” Hepatology 22(4 Part 2):158A Abstract No. 206 (1995). |
Katsuragi et al., “A case of gall bladder cancer with high level alpha-fetoprotein” Japan J. Clin. Radiol. 34:371-374 (1989). |
Kawamoto et al., “Alpha-fetoprotein-producing pancreatic cancer—A case report and review of 28 cases” Hepato-Gastroentrol. 39:282-286 (1992). |
Koyama et al., “Biochemical characterization of alpha-fetoprotein and other serum proteins produced by a uterine-endometrial adenocarcinoma” Jpn. J. Cancer Res. 87:612-617 (1996). |
Lamb et al., “Nucleotide sequence of cloned cDNA coding for preproricin” Eur. J. Biochem. 148:265-270 (1985). |
Latimer et al., “Specificity of monoclonal antibodies produced against phosphorothioate and ribo modified DNAs” Mol. Immunol. 32(14/15):1057-1064 (1995). |
Le Gal Le Salle et al., “An adenovirus vector for gene transfer into neurons and glia in the brain” Science 259:988-990 (1993). |
Mastrangeli et al., “Diversity of airway epithelial cell targets for in vivo recombinatn adenovirus-mediated gene transfer” J. Clin. Invest. 91:225-234 (1993). |
Maxwell et al., “Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain” Mol. Cell. Biol. 7:1576-1579 (1987). |
McKinnon, “Tn5 mutatgenesis of the transforming genes of human adenovirus type 5” Gene 19:33-42 (1982). |
Messing et al., “P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice” Neuron 8:507-520 (1992). |
Nakabayashi et al., “A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma” Mol. Cell. Biol. 11(12):5885-5893 (1991). |
Nevins, “Mechanisms of viral-mediated trans-activation of transcription” Adv. Virus Res. 37:35-83 (1989). |
Palmiter et al., “Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene” Cell 50:435-443 (1987). |
Peyrottes et al., “Oligodeoxynucleoside phosphoramidates (P-NH2): synthesis and thermal stability of duplexes with DNA and RNA targets” Nucleic Acids Res. 24(10):1841-1848 (1996). |
Piatak et al., “Expression of soluble and fully functional ricin A chain in escherichia coli is temperature-sensitive” J. Biol. Chem. 263(10):4837-4843 (1988). |
Quantin et al., “Adenovirus as an expression vector in muscle cells in vivo” Proc. Natl. Acad. Sci. USA 89:2581-3584 (1992). |
Ragot et al., “Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice” Nature 361:647-650 (1993). |
Rodriguez et al., “Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive cancer cells.” Cancer Res. 57:2559=2563 (1997). |
Rosenfeld et al., “Adenovirus-mediated transfer of a recombinant alpha1-antitrypsin gene to the lung epithelium in vivo” Science 252:431-434 (1991). |
Rosenfeld et al., “In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium” Cell 68:143-155 (1992). |
Sakai et al., “The human alpha-fetoprotein gene” J. Biol. Chem. 2608):5055-5060 (1985). |
Scaria et al., Virology vol. 191, pp. 743-753 (1992). |
Schultz et al., “Oligo-2′-fluoro-2′-deoxynucleotide N3′-P5′ phosphoramidates: synthesis and properties” Nucleic Acids Res. 24(15):2966-73 (1996). |
Stratford-Perricaudet et al., “Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector” Human Gene Therapy 1:241-256 (1990). |
Stratford-Perricaudet et al., “Widespread long term gene transfer to mouse skeletal muscles and heart” J. Clin. Invest. 90:626-630 (1992). |
Swaminathan et al., “Regulation of adenovirus E2 transcription unit” Curr. Topics in Microbiol. And Immunol. 199 part 3:177-194 (1995). |
Takiff et al., “Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells” Lancet 11:832-834 (1981). |
Tollefson et al., “The 11,600-Mw protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection” J. Virol. 66(6):3633-3642 (1992). |
Tollefson et al., “The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells” J. Virol. 70(4):2296-2306 (1996). |
Virtanen et al., “mRNAs from human adenovirus 2 early region 4” J. Virol. 51(3):822-831 (1984). |
Wang et al., “Expression of the APRT gene in an adenovirus vector system as a model for studying gene therapy” Adv. Exp. Med. Biol. 309B:61-66 (1991). |
Watanabe et al., “Cell Specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene” J. Biol. Chem. 262(10):4812-4818 (1987). |
Weinberg et al., “A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2” Proc. Natl. Acad. Sci. USA 80:5383-5386 (1983). |
Wen et al., “Enhancer, repressor, and promoter specificities combine to regulate the rat alpha-fetoprotein gene” DNA Cell Biol. 10(7):525-536 (1991). |
Wen et al., “A promoter-linked coupling region required for stimulation of alpha-fetoprotein transcription by distant enhancers” Nucl. Acids Res. 21(8):1911-1918 (1993). |
Wills et al., “Gene therapy for hepatocellular carcinoma: chemosentiveity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene,” Cancer Gene Ther. 2:191=197 (1995). |